Samuel C. Wadsworth

5.4k citations

68 papers · 4.4k indexed · h-index 34

Genetics top 0.5%
- Virus-based gene therapy research 32
Molecular Biology top 2%
- Viral Infectious Diseases and Gene Expression in Insects 15
- RNA Interference and Gene Delivery 12
- CRISPR and Genetic Engineering 6
Ophthalmology top 2%
- Retinal Diseases and Treatments 8
Cell Biology top 5%
Infectious Diseases top 5%
- Viral gastroenteritis research and epidemiology 7
Epidemiology
- Herpesvirus Infections and Treatments 7
Pulmonary and Respiratory Medicine
- Cystic Fibrosis Research Advances 6

Co-authors: Bernard Roizman Robert J. K. Jacob Alan E. Smith Catherine R. O’Riordan Gary S. Hayward Richard J. Gregory Richard B. Vallee Johanne Kaplan
Cited by: Genetics Molecular Biology Ophthalmology
Journals: Nature (2 papers)Cell (1 paper)Proceedings of the National Academy of Sciences (3 papers)
Partner nations: United States France United Kingdom

In The Last Decade

Samuel C. Wadsworth

68 papers receiving 4.1k citations

Peers

Countries citing papers authored by Samuel C. Wadsworth

Since Specialization

Citations

This map shows the geographic impact of Samuel C. Wadsworth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel C. Wadsworth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel C. Wadsworth more than expected).

Fields of papers citing papers by Samuel C. Wadsworth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel C. Wadsworth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel C. Wadsworth. The network helps show where Samuel C. Wadsworth may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Samuel C. Wadsworth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Samuel C. Wadsworth Line = papers co-authored together Samuel C. Wadsworth links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Determining the Minimally Effective Dose of a Clinical Candidate Adeno-Associated Virus Vector in a Mouse Model of Hemophilia A Human Gene Therapy ·Jenny A. Greig,Melanie K. Smith,Jayme M.L. Nordin,Tamara Goode,Edward A. Chroscinski,Elizabeth L. Buza,Nicole Schmidt,Lisa Kattenhorn,Samuel C. Wadsworth,James M. Wilson	2021	2
2	Aurintricarboxylic acid increases yield of HSV-1 vectors Molecular Therapy — Methods & Clinical Development ·Peter Pecháň,Jeffery Ardinger,Jyothi Ketavarapu,Hillard Rubin,Samuel C. Wadsworth,Abraham Scaria	2014	4
3	AAV5-mediated sFLT01 gene therapy arrests retinal lesions in Ccl2−/−/Cx3cr1−/− mice Neurobiology of Aging ·Jingsheng Tuo,Jijing Pang,Xiaoguang Cao,Defen Shen,Jun Zhang,Abraham Scaria,Samuel C. Wadsworth,Peter Pecháň,Sanford L. Boye,William W. Hauswirth,Chi‐Chao Chan	2011	19
4	Inhibition of Choroidal Neovascularization in a Nonhuman Primate Model by Intravitreal Administration of an AAV2 Vector Expressing a Novel Anti-VEGF Molecule Molecular Therapy ·Michael Lukason,Elizabeth DuFresne,Hillard Rubin,Peter Pecháň,Qiuhong Li,Ivana K. Kim,Szilárd Kiss,Christina J. Flaxel,Margaret E. Collins,Joan W. Miller,William W. Hauswirth,Timothy K. MacLachlan,Samuel C. Wadsworth,Abraham Scaria	2010	67
5	A Constitutively Active Hypoxia-Inducible Factor-1α/VP16 Hybrid Factor Activates Expression of the Human B-Type Natriuretic Peptide Gene Molecular Pharmacology ·Yuxia Luo,Canwen Jiang,Adam J. Belanger,Geoffrey Y. Akita,Samuel C. Wadsworth,Richard J. Gregory,Karen A. Vincent	2006	36
6	Delivery of CFTR by adenoviral vector to cystic fibrosis mouse lung in a model of chronic Pseudomonas aeruginosa lung infection American Journal of Physiology-Lung Cellular and Molecular Physiology ·Anna M. van Heeckeren,Abraham Scaria,Mark Schluchter,Thomas W. Ferkol,Samuel C. Wadsworth,Pamela B. Davis	2004	26
7	Targeting adenoviral vectors using heterofunctional polyethylene glycol FGF2 conjugates Molecular Therapy ·Julia Lanciotti,Antonius Song,John A. Doukas,Barbara A. Sosnowski,Glenn F. Pierce,Richard J. Gregory,Samuel C. Wadsworth,Catherine R. O’Riordan	2003	89
8	AAV2 Vector Harboring a Liver-Restricted Promoter Facilitates Sustained Expression of Therapeutic Levels of α-Galactosidase A and the Induction of Immune Tolerance in Fabry Mice Molecular Therapy ·Robin J. Ziegler,Scott Lonning,Donna Armentano,Chester Li,David W. Souza,Maribeth Cherry,C. W. Ford,Christine M. Barbon,Robert J. Desnick,Guangping Gao,James M. Wilson,Richard Peluso,Simon Godwin,Barrie J. Carter,Richard J. Gregory,Samuel C. Wadsworth,Seng H. Cheng	2003	111
9	Adenoviral Vector Expressing ICP47 Inhibits Adenovirus-Specific Cytotoxic T Lymphocytes in Nonhuman Primates Molecular Therapy ·Abraham Scaria,Jennifer A. Sullivan,Judith A. St. George,Johanne Kaplan,Michael Lukason,James E. Morris,Malinda S. Plog,Charles Nicolette,Richard J. Gregory,Samuel C. Wadsworth	2000	10
10	Modification of an Adenoviral Vector with Biologically Selected Peptides: A Novel Strategy for Gene Delivery to Cells of Choice Human Gene Therapy ·H Romanczuk,Chad E. Galer,Joseph Zabner,Gary Barsomian,Samuel C. Wadsworth,Catherine R. O’Riordan	1999	113
11	PEGylation of Adenovirus with Retention of Infectivity and Protection from Neutralizing Antibody in Vitro and in Vivo Human Gene Therapy ·Catherine R. O’Riordan,Amy Lachapelle,Cristina Delgado,Vincent Parkes,Samuel C. Wadsworth,Alan E. Smith,G. E. Francis	1999	334
12	Potentiation of Gene Transfer to the Mouse Lung by Complexes of Adenovirus Vector and Polycations Improves Therapeutic Potential Human Gene Therapy ·Johanne Kaplan,Sarah E. Pennington,Judith A. St. George,Lisa Woodworth,A Fasbender,John Marshall,Seng H. Cheng,Samuel C. Wadsworth,Richard J. Gregory,Alan E. Smith	1998	70
13	Safety of Airway Gene Transfer with Ad2/CFTR2: Aerosol Administration in the Nonhuman Primate Human Gene Therapy ·Ruth J. McDonald,Michael Lukason,Otto G. Raabe,Don R. Canfield,Elizabeth A. Burr,Johanne Kaplan,Samuel C. Wadsworth,Judith A. St. George	1997	21
14	Characterization of Factors Involved in Modulating Persistence of Transgene Expression from Recombinant Adenovirus in the Mouse Lung Human Gene Therapy ·Johanne Kaplan,Donna Armentano,Tim E. Sparer,Susan G. Wynn,Pamela A. Peterson,Samuel C. Wadsworth,Kristen K. Couture,Sarah E. Pennington,Judith A. St. George,L R Gooding,Alan E. Smith	1997	89
15	Adeno-associated virus 2-mediated gene transfer in vivo: organ-tropism and expression of transduced sequences in mice Gene ·Selvarangan Ponnazhagan,Pinku Mukherjee,Mervin C. Yöder,Xu-Shan Wang,Shang Zhen Zhou,Johanne Kaplan,Samuel C. Wadsworth,Arun Srivastava	1997	103
16	Tissue-Specific Expression of Human CD4 in Transgenic Mice Molecular and Cellular Biology ·Frances P. Gillespie,Linda Doros,James Vitale,Catherine Blackwell,Joe Gosselin,Benjamin W. Snyder,Samuel C. Wadsworth	1993	7
17	Protein‐tyrosine kinase activity of alternate protien products of the Drosophila Dsrc28C locus FEBS Letters ·Steven J. Theroux,Samuel C. Wadsworth	1992	2
18	Multiple forms of dynamin are encoded by shibire, a Drosophila gene involved in endocytosis Nature ·Maio S. Chen,Robert A. Obar,Christopher C. Schroeder,Timothy W. Austin,Clifton A. Poodry,Samuel C. Wadsworth,Richard B. Vallee	1991	466
19	Differential expression of alternate forms of a Drosophila src protein during embryonic and larval tissue differentiation Developmental Biology ·Samuel C. Wadsworth,F. A. Muckenthaler,Walter S. Vincent	1990	16
20	Drosophila src family proteins Comparative Biochemistry and Physiology Part B Comparative Biochemistry ·Samuel C. Wadsworth	1990	3

About Samuel C. Wadsworth

Samuel C. Wadsworth is a scholar working on Genetics, Ophthalmology and Molecular Biology, having authored 68 papers that have together received 4.4k indexed citations. Recurring topics across this work include Virus-based gene therapy research (32 papers), Viral Infectious Diseases and Gene Expression in Insects (15 papers), RNA Interference and Gene Delivery (12 papers), Retinal Diseases and Treatments (8 papers), Viral gastroenteritis research and epidemiology (7 papers), Herpesvirus Infections and Treatments (7 papers), CRISPR and Genetic Engineering (6 papers) and Cystic Fibrosis Research Advances (6 papers). The work is most often cited by research in Genetics (2.3k citations), Molecular Biology (3.0k citations) and Ophthalmology (271 citations). Samuel C. Wadsworth has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Bernard Roizman, Robert J. K. Jacob, Alan E. Smith, Catherine R. O’Riordan, Gary S. Hayward, Richard J. Gregory, Richard B. Vallee, Johanne Kaplan, Judith A. St. George and Brian J. McCarthy. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact